Metabolic Reprogramming of Sulfur in Hepatocellular Carcinoma and Sulfane Sulfur-Triggered Anti-Cancer Strategy

被引:14
|
作者
Zhang, Ximing [1 ]
Chen, Mianrong [1 ]
Ni, Xiang [2 ]
Wang, Yingying [3 ]
Zheng, Xue [1 ]
Zhang, Hui [1 ]
Xu, Shi [2 ]
Yang, Chun-tao [1 ]
机构
[1] Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou Municipal & Guangdong Prov Key Lab Prot, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China
[2] Brown Univ, Dept Chem, Providence, RI 02912 USA
[3] Washington State Univ, Dept Chem, Pullman, WA 99164 USA
关键词
bioinformatics; hepatocellular carcinoma; metabolic reprogramming; reactive sulfur species; sulfane sulfur; HYDROGEN-SULFIDE; VITAMIN-B6; METABOLISM; CANCER; PROLIFERATION; BIOLOGY;
D O I
10.3389/fphar.2020.571143
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabolic reprogramming is a cancer hallmark. Although the reprogramming of central carbon has been well documented, the role of sulfur metabolism has been largely overlooked. Additionally, the effects of sulfur are sometimes contradictory in tumorigenesis. In this study, we aimed to investigate the gene expression profile in hepatocellular carcinoma (HCC) and the effects of reactive sulfur species (RSS) on HCC tumor cells. Furthermore, the cell imaging technology was applied to discover some potential anti-cancer compounds. Gene Set Enrichment Analysis (GSEA) of Gene Expression Omnibus (GEO) dataset (GSE102083) revealed that sulfur amino acid-related metabolism and vitamin B(6)binding activity in HCC tissues were downregulated. Calculation of the interaction network identified nine hub genes, among which eight were validated by differential expression and survival analysis in the TCGA_LIHC cohort, and two (CSE and CBS) had the highest enrichment degree. The metabolomics analysis suggested that the hub genes were associated with RSS metabolism including H2S, H2S2, cystine, cysteine, homocysteine, cystathionine, and methionine. The cell viability assay demonstrated that H(2)S(2)had significant anti-cancer effects in HCC SNU398 tumor cells. The cell imaging assay showed that treatment with H(2)S(2)remarkably increased intracellular sulfane sulfur content. On this basis, the anti-cancer activity of some other sulfane sulfur compounds, such as DATS and DADS, was further verified. Lastly, according to the fact that HCC tumor cells preferentially take in cystine due to high expression of SLC7A11 (a cystine/glutamate transporter), persulfided cysteine precursor (PSCP) was tested for its sulfane sulfur release capability and found to selectively inhibit HCC tumor cell viability. Collectively, this study uncovered sulfur metabolism in HCC was reprogrammed, and provided a potential therapeutic strategy for HCC by donating sulfane sulfur.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
    Zhang, Jing
    Bai, Jian
    Gong, Chen
    Wang, Jianhua
    Cheng, Yi
    Zhao, Jing
    Xiong, Huihua
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [2] Mitochondrial dysfunction-driven AMPK-p53 axis activation underpins the anti-hepatocellular carcinoma effects of sulfane sulfur
    Zheng, Xue
    Luo, Yuhua
    Huo, Rui
    Wang, Yiwen
    Chen, Youbang
    Chen, Mianrong
    Zhao, Qi
    Li, Kexin
    Zhang, Hanyi
    Li, Xiaotong
    Li, Xiang
    Zhang, Hui
    He, Zaopeng
    Huang, Li
    Yang, Chun-tao
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [3] Pamidronate has anti-cancer potential in hepatocellular carcinoma
    Wada, Akira
    Tamura, Shinji
    Fukui, Koji
    Kiso, Shinichi
    Hayashi, Norio
    HEPATOLOGY, 2006, 44 (04) : 531A - 531A
  • [4] Targeting the Metabolic Mevalonate Pathway as an Anti-Cancer Strategy
    Penn, L. Z.
    PANCREAS, 2017, 46 (07) : 962 - 962
  • [5] Enhancing effect of retinoids on anti-cancer drugs by regulating the metabolic pathways of hepatocellular carcinoma cells
    Shiota, Goshi
    Kanki, Keita
    HEPATOLOGY, 2014, 60 : 644A - 644A
  • [6] Targeted Silencing of Inhibitors of Apoptosis Proteins with siRNAs: A Potential Anti-cancer Strategy for Hepatocellular Carcinoma
    Li, Gang
    Chang, Hong
    Zhai, Yun-Peng
    Xu, Wei
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (09) : 4943 - 4952
  • [7] A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer
    Wu, Bao-Kang
    Chen, Qian-Hui
    Pan, Dan
    Chang, Bing
    Sang, Li-Xuan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [8] Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
    Liem Minh Phan
    Sai-Ching Jim Yeung
    Mong-Hong Lee
    Cancer Biology & Medicine, 2014, (01) : 1 - 19
  • [9] Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
    Liem Minh Phan
    SaiChing Jim Yeung
    MongHong Lee
    Cancer Biology & Medicine, 2014, 11 (01) : 1 - 19
  • [10] Metabolic Reprogramming of Anti-cancer T Cells: Targeting AMPK and PPAR to Optimize Cancer Immunotherapy
    Jalil, Abduldaheem Turki
    Al-Kazzaz, Hassan Hadi
    Hassan, Firas A.
    Mohammed, Safaa Halool
    Merza, Muna S.
    Aslandook, Tahani
    Elewadi, Ahmed
    Fadhil, Ali
    Alsalamy, Ali
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2025, 40 (02) : 165 - 175